← Evidence map

ArticleCancer chemotherapy and pharmacology2025

HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLC.

Kunihiko Funaishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39853458